Although standardized assays are used to help select patients for anti-HER2 therapy, there are no standardized criteria for assessing HER2 as a prognostic marker.

• 虽然选择哪些患者进行抗-HER2治疗有一套检验标准，但是通过评价HER2的表达来判断预后仍无标准可依。